These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5754252)

  • 81. [Mechanism of action of sulfones in leprosy; activity of monoisopropyl sulfone and diisopropyl sulfone administered by mouth].
    DEHEZ F; FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(400):1-8. PubMed ID: 13395621
    [No Abstract]   [Full Text] [Related]  

  • 82. [Control of leprosy: fantasies and possibilities].
    Browne SG
    Acta Leprol; 1980; (81):27-33. PubMed ID: 6785980
    [No Abstract]   [Full Text] [Related]  

  • 83. Epidemiology of leprosy in rural population of Pondicherry.
    Lal S; Mahalingam C; Garg BR
    Lepr India; 1982 Oct; 54(4):677-84. PubMed ID: 7183834
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Use of corticosteroids in persistent "lepra reaction".
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1966 Jan; 14(1):16-7. PubMed ID: 5961035
    [No Abstract]   [Full Text] [Related]  

  • 85. Steroid therapy and leprosy.
    Ramu G
    Indian J Lepr; 1996; 68(2):182-3. PubMed ID: 8835589
    [No Abstract]   [Full Text] [Related]  

  • 86. Langerhans cell and leprosy.
    Mathur NK; Mangal HN; Mathur D; Bedwal RS; Mathur RS
    Lepr India; 1983 Jan; 55(1):22-8. PubMed ID: 6876758
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The etiology of erythema nodosum leprosum.
    Pettit JH; Waters MF
    Int J Lepr Other Mycobact Dis; 1967; 35(1):1-10. PubMed ID: 6067035
    [No Abstract]   [Full Text] [Related]  

  • 88. [Comparative therapeutic value of sulfones, chaulmooga and thiosemicarbazones in leprosy].
    SCHUJMAN S
    Prensa Med Argent; 1955 Jan; 42(3):183-90. PubMed ID: 14371409
    [No Abstract]   [Full Text] [Related]  

  • 89. Leprosy scenario in Agra: epidemiological observations from rapid population survey 2004-06.
    Kumar A; Chakma JK; Yadav VS; Girdhar A; Girdhar BK
    J Commun Dis; 2008 Dec; 40(4):277-84. PubMed ID: 19579721
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Leprosy disease in Nepal : knowledge and non-compliance of patients.
    Chalise SC
    JNMA J Nepal Med Assoc; 2005; 44(158):39-43. PubMed ID: 16554869
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Clinical results of the therapeutic action of a combined sulfonamide-sulfone preparation in several cases of gonococcic and non-gonococcic urethritis].
    BACCANELLI F
    Minerva Dermatol; 1958 Aug; 33(8):319-20. PubMed ID: 13589764
    [No Abstract]   [Full Text] [Related]  

  • 92. [Utilization in pediatrics of a delayed-action sulfamide combination].
    Péan G; Gaumont A
    Ann Pediatr (Paris); 1967 Mar; 14(3):260-1. PubMed ID: 5614551
    [No Abstract]   [Full Text] [Related]  

  • 93. Letter: Sulphone resistance in leprosy.
    Crawford CL
    Lancet; 1975 Aug; 2(7928):280. PubMed ID: 49828
    [No Abstract]   [Full Text] [Related]  

  • 94. [Clinical and electroencephalographic observations on the action of new antiepileptic drug: "Caducid Wassermann" (p-fluorophenylethylsulfone)].
    Maccagnani F
    Riv Neurol; 1966; 36(4):437-42. PubMed ID: 5968447
    [No Abstract]   [Full Text] [Related]  

  • 95. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V; Porichha D
    Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Leprosy.
    Hendrick SS; Wilkin JK
    Am Fam Physician; 1982 Nov; 26(5):161-6. PubMed ID: 7148625
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Application of lot quality assurance sampling for leprosy elimination monitoring--examination of some critical factors.
    Gupte MD; Murthy BN; Mahmood K; Meeralakshmi S; Nagaraju B; Prabhakaran R
    Int J Epidemiol; 2004 Apr; 33(2):344-8. PubMed ID: 15082637
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Disabilities in leprosy.
    Kalla G; Kachhawa D; Salodkar A
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):182-4. PubMed ID: 11036502
    [No Abstract]   [Full Text] [Related]  

  • 99. Sulphamethoxypyraxine in the treatment of leprosy.
    Trimigliozzi G
    Panminerva Med; 1966 Mar; 8(3):76-9. PubMed ID: 5325787
    [No Abstract]   [Full Text] [Related]  

  • 100. [Treatment of leprosy, particularly the tuberculoid form, with streptomycin, alone and with sulfones].
    RAMOS E SILVA J; PERYASSU D
    Bras Med; 1954; 68(32-52):439-50. PubMed ID: 14363492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.